Literature DB >> 10873151

Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells.

M C Seeds1, K A Jones, R Duncan Hite, M C Willingham, H M Borgerink, R D Woodruff, D L Bowton, D A Bass.   

Abstract

Secretory phospholipase A(2) (sPLA(2)) enzymes contribute to inflammatory injury in human lungs by several mechanisms, including eicosanoid production and hydrolytic damage to surfactant phospholipids. Several distinct sPLA(2) genes have been described in human tissue but little is known regarding their presence, localization, or function(s) within lungs. We hypothesized that sPLA(2)s would have cell-specific distributions within lung. We used reverse transcriptase/polymerase chain reaction to identify sPLA(2) messenger RNAs (mRNAs) in adult human lung tissue. Resulting complementary DNA (cDNA) sequences indicated that total lung extracts contained mRNA for Groups IB, IIA, V, and X sPLA(2). An epithelial cell line, BEAS cells, expressed only Groups IIA, V, and X. We used these cDNAs to clone these enzymes, especially the recently described Group X and Group V enzymes. Digoxigenin-labeled complementary RNA probes were used to determine localization of each sPLA(2) by in situ hybridization of human lung. Hybridization was strongly positive for Group X and Group V in airway epithelial cells, which failed to hybridize Group IB or IIA probes. Although four known mammalian sPLA(2) isotypes were expressed in lung, only Group X and Group V sPLA(2) mRNAs appear uniquely expressed in airway epithelium, suggesting they could provide a mechanism of pulmonary surfactant hydrolysis during lung injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873151     DOI: 10.1165/ajrcmb.23.1.4034

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

Review 1.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

2.  Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation.

Authors:  Shin Ohta; Mitsuru Imamura; Wei Xing; Joshua A Boyce; Barbara Balestrieri
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

3.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

4.  Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina.

Authors:  Panagiotis I Sergouniotis; Alice E Davidson; Donna S Mackay; Eva Lenassi; Zheng Li; Anthony G Robson; Xu Yang; Jaimie Hoh Kam; Timothy W Isaacs; Graham E Holder; Glen Jeffery; Jonathan A Beck; Anthony T Moore; Vincent Plagnol; Andrew R Webster
Journal:  Am J Hum Genet       Date:  2011-12-01       Impact factor: 11.025

5.  Secretory phospholipases A2 are secreted from ciliated cells and increase mucin and eicosanoid secretion from goblet cells.

Authors:  Tsuyoshi Tanabe; Tadasuke Shimokawaji; Soichiro Kanoh; Bruce K Rubin
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

6.  Group X secreted phospholipase A2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells.

Authors:  Ikram Jemel; Hiromi Ii; Rob C Oslund; Christine Payré; Anne-Sophie Dabert-Gay; Dominique Douguet; Khaoula Chargui; Sabine Scarzello; Michael H Gelb; Gérard Lambeau
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

7.  Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells.

Authors:  Seiko Masuda; Makoto Murakami; Michiko Mitsuishi; Kazuo Komiyama; Yukio Ishikawa; Toshiharu Ishii; Ichiro Kudo
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

8.  Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.

Authors:  Norbert Degousee; David J Kelvin; Gerd Geisslinger; David M Hwang; Eva Stefanski; Xing-Hua Wang; Ali Danesh; Carlo Angioni; Helmut Schmidt; Thomas F Lindsay; Michael H Gelb; James Bollinger; Christine Payré; Gérard Lambeau; Jonathan P Arm; Armand Keating; Barry B Rubin
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

9.  Inhibition of LPS-induced chemokine production in human lung endothelial cells by lipid conjugates anchored to the membrane.

Authors:  G Ch Beck; B A Yard; J Schulte; R Oberacker; K van Ackern; F J van Der Woude; M Krimsky; M Kaszkin; S Yedgar
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

10.  PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation.

Authors:  Munehiro Yamaguchi; Jennifer Zacharia; Tanya M Laidlaw; Barbara Balestrieri
Journal:  J Leukoc Biol       Date:  2016-03-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.